Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-068063
Filing Date
2008-03-28
Accepted
2008-03-28 07:01:00
Documents
7
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 736301
2 SUBSIDIARIES OF REGISTRANT dex211.htm EX-21.1 1855
3 CONSENT OF DELOITTE & TOUCHE LLP dex231.htm EX-23.1 2100
4 CERTIFICATION PURSUANT TO RULE 13A-14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 dex311.htm EX-31.1 9993
5 CERTIFICATION PURSUANT TO RULE 13A-14(A) OF THE SECURITIES EXCHANGE ACT OF 1934 dex312.htm EX-31.2 9961
6 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 dex321.htm EX-32.1 5263
7 CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 dex322.htm EX-32.2 5296
  Complete submission text file 0001193125-08-068063.txt   772175
Mailing Address 189 WELLS ST STE 200 NEWTON MA 02459
Business Address 189 WELLS ST STE 200 NEWTON MA 02459 6175590033
PRO PHARMACEUTICALS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31791 | Film No.: 08716701
SIC: 2834 Pharmaceutical Preparations